Skip to main content
Clinical Trials/NCT00155337
NCT00155337CompletedPhase 4

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

National Taiwan University Hospital2 sites in 1 country40 target enrollmentStarted: August 2004Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
End of 8 treatments

Study Overview

Brief Summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Detailed Description

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with leukoplakia or erythroleukoplakia

Exclusion Criteria

  • oral cancers

Outcomes

Primary Outcomes

End of 8 treatments

Secondary Outcomes

  • Regression of lesions

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials